Form 4: Artivion SVP Jean F. Holloway Reports Stock Transactions
SEC Form 4
Jean F. Holloway, SVP and General Counsel of Artivion, Inc., reports acquisition of shares through performance stock units and sale of shares to cover tax obligations.
Summary
- Jean F. Holloway, a Senior Vice President and General Counsel at Artivion, Inc., filed a Form 4 detailing changes in beneficial ownership of the company's stock.
- On March 6, 2025, Holloway acquired 25,493 shares of common stock related to performance stock units granted on February 23, 2024.
- One-third of these units vested on March 6, 2025, with the remaining shares vesting in two equal installments on February 23, 2026, and February 23, 2027, contingent upon continued employment.
- On the same day, Holloway sold 2,124 shares at a price of $24.8048 per share to cover tax withholding obligations associated with the vesting of the performance stock units.
- Following these transactions, Holloway directly owns 196,112 shares of Artivion, Inc. common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the document primarily reports routine stock transactions. The acquisition of shares is a positive sign, but the sale to cover taxes is a standard practice and doesn't necessarily indicate a negative outlook.
Positives
- The acquisition of shares indicates a potential alignment of Holloway's interests with the company's performance.
- The vesting of performance stock units suggests that Holloway has met certain performance criteria.
Negatives
- The sale of shares, even for tax obligations, could be perceived negatively by some investors, although it is a common practice.
Risks
- Future vesting of performance stock units is contingent upon continued employment, creating a potential risk if Holloway were to leave the company.
- The market price of Artivion's stock could fluctuate, impacting the value of Holloway's holdings.
Future Outlook
The remaining performance stock units will vest on February 23, 2026, and February 23, 2027, assuming continued employment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is common in publicly traded companies. It provides transparency into the ownership changes of key personnel.
Comparison to Industry Standards
- Stock transactions by company executives are regularly monitored and reported in compliance with SEC regulations.
- Companies like Medtronic, Abbott, and Boston Scientific also have executives who regularly report stock transactions via Form 4 filings.
- The 'sell to cover' transaction for tax obligations is a standard practice among executives receiving equity compensation.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- Shareholders may view the insider's stock ownership as a sign of confidence in the company.
Key Dates
| Date | Description |
|---|---|
| February 23, 2024 | Date of grant for performance stock units. |
| March 6, 2025 | Date of stock acquisition and sale for tax obligations. |
| February 23, 2026 | Next vesting date for one-third of the remaining performance stock units. |
| February 23, 2027 | Final vesting date for one-third of the remaining performance stock units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.